A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol.
Saved in:
| Title: | A pan-European register-based observational study of abrocitinib and conventional systemic therapies in moderate and severe atopic dermatitis: the DREAM TO TREAT AD study protocol. |
|---|---|
| Authors: | Gribaleva E; Unit for Paediatric and Population-Based Dermatology Research, St John's Institute of Dermatology, King's College London, London, UK., Krogh NS; ZiteLab Aps, Copenhagen, Denmark., Prieto-Merino D; Unit for Paediatric and Population-Based Dermatology Research, St John's Institute of Dermatology, King's College London, London, UK.; Faculty of Medicine, University of Alcalá, Alcalá de Henares, Spain., Coker B; Research and Development Department, Guy's and St Thomas' NHS Foundation Trust, London, UK., Jackson A; Pfizer Healthcare Ireland, Dublin, Ireland., Akkoc A; ZiteLab Aps, Copenhagen, Denmark., Birkner T; Center for Evidence-Based Healthcare, University Hospital Carle Gustav Carus Dresden and Medical Faculty, TU Dresden, Dresden, Sachsen, Germany., Bruninx E; Pfizer NV/SA, Brussels, Belgium., Hennessy C; National and International Skin Registry Solutions CLG, Charles Institute of Dermatology, University College Dublin, Dublin, Ireland., Chan K; St John's Institute of Dermatology, Guy's and St Thomas' Hospitals NHS Trust, London, UK.; School of Public Health, Brown University, Providence, RI, USA., Cutlar L; National and International Skin Registry Solutions CLG, Charles Institute of Dermatology, University College Dublin, Dublin, Ireland., Farrell B; National and International Skin Registry Solutions CLG, Charles Institute of Dermatology, University College Dublin, Dublin, Ireland., Fletcher G; National and International Skin Registry Solutions CLG, Charles Institute of Dermatology, University College Dublin, Dublin, Ireland., Gerbens L; Department of Dermatology, Amsterdam Public Health & Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Frostrup AG; Pfizer ApS, Ballerup, Denmark., Henrohn D; Pfizer AB, Stockholm, Sweden.; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Hyseni A; Department of Dermatology, Amsterdam Public Health & Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Irvine AD; Department of Clinical Medicine, Trinity College, Dublin, Ireland., Malek R; Department of Life Sciences and Medicine, King's College London, London, UK., McCarthy C; Pfizer Healthcare Ireland, Dublin, Ireland., Vittrup I; Department of Dermatology, Copenhagen University Hospital, Copenhagen, Denmark., Ouwerkerk W; Department of Dermatology, Amsterdam Public Health & Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Randall R; Pfizer Ltd, Tadworth, UK., Spuls PI; Department of Dermatology, Amsterdam Public Health & Infection and Immunity, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands., Thomsen SF; Department of Dermatology, Copenhagen University Hospital, Copenhagen, Denmark., Wall D; Hair Restoration Blackrock, Dublin, Ireland.; Charles Institute of Dermatology, School of Medicine, University College Dublin, Dublin, Ireland., Weidinger S; Department of Dermatology and Allergy, University Hospital Schleswig Holstein, Kiel, Schleswig-Holstein, Germany., Werfel T; Department of Dermatology, Hannover Medical School, Hannover, Germany., Schmitt J; Center for Evidence-Based Healthcare, University Hospital Carle Gustav Carus Dresden and Medical Faculty, TU Dresden, Dresden, Sachsen, Germany., Flohr C; Unit for Paediatric and Population-Based Dermatology Research, St John's Institute of Dermatology, King's College London, London, UK. |
| Source: | Skin health and disease [Skin Health Dis] 2025 Apr 22; Vol. 5 (3), pp. 196-202. Date of Electronic Publication: 2025 Apr 22 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 9918227353706676 Publication Model: eCollection Cited Medium: Internet ISSN: 2690-442X (Electronic) Linking ISSN: 2690442X NLM ISO Abbreviation: Skin Health Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
